Confirm Biosciences, Inc.

Confirm Biosciences, Inc. is a company focused on developing and distributing drug and health testing kits that enable informed decision-making across various sectors, including employers and government organizations. Founded in 2008 in San Diego, US, Confirm Biosciences specializes in drug and health testing solutions. The company was established by Serhat Pala and Zeynep Ilgaz.

Under the leadership of CEO Albert Berger, it has engaged in one significant deal as of March 26, 2019. Confirm Biosciences specializes in the development and distribution of drug and health testing kits designed to facilitate informed decision-making for various sectors, including employers, retailers, and government entities. Their core product offerings encompass a range of comprehensive screening tools that provide accurate results in a matter of minutes. These tests function by analyzing biological samples, enabling users to obtain actionable information about substance use and health indicators.

The company’s product line is geared towards enhancing workplace safety, compliance, and overall health management. Serving a diverse client base across the United States, Confirm Biosciences extends its reach internationally, catering to businesses in multiple geographical markets including North America, Europe, and Asia. Confirm Biosciences generates revenue through direct sales of its drug and health testing kits to businesses and organizations, including retailers and corporate clients. Transactions typically occur on a B2B basis, where clients place orders for testing kits that meet their specific needs.

The company’s pricing structure is based on the volume of products ordered, offering tailored solutions for larger clients and bulk purchases. In addition to standard product sales, Confirm Biosciences may engage in partnerships and collaborations with retailers to broaden market access. Their flagship offerings, known for their reliability and quick results, play a significant role in driving business transactions. Confirm Biosciences aims to enhance its market presence with the introduction of new products designed to meet emerging health testing needs.

The company is targeting expansions into additional markets in North America, Europe, and Asia by 2025. The recent funding received will support these initiatives, facilitating product development and market penetration strategies.